The NSF has awarded SDSC a $5 million grant to develop a high-performance resource for conducting artificial intelligence (AI) research across a wide swath of science and engineering domains.
Researchers from Harvard University and the University of Texas Medical Branch at Galveston recently used the Comet supercomputer at the San Diego Supercomputer Center at the University of California San Diego to uncover the novel ways in which DNA prepares itself for repair.
The Sherlock Division of SDSC has broadened its secure Cloud solutions portfolio to offer Skylab, an innovative customer-owned Cloud platform solution that provides a self-standing, compliant environment for secure workloads in the Amazon Web Services (AWS) Cloud.
SDSC's Sherlock Division has expanded its multi-Cloud solution, Sherlock Cloud, to include the Google Cloud Platform (GCP) in addition to AWS and Microsoft Azure.
The U.S. Department of Defense’s (DoD) Defense STEM Education Consortium (DESC) has awarded a one-year grant to SDSC and the UC San Diego Mathematics Project to introduce computing into high school math classrooms.
The National Science Foundation awards two SDSC researchers funding to organize COVID-19 information into a knowledge network that integrates health, pathogen, and environmental data to track cases across greater San Diego.
Using supercomputers, scientists have developed for the first time a way to screen drugs through their chemical structures for induced arrhythmias.
Program makes COVID-19 testing available to thousands of students in effort to track the novel coronavirus and better position the campus to resume in-person activities in the fall.
UC San Diego researchers have ported the popular UniFrac microbiome tool to graphic processing units (GPUs) to increase the acceleration and accuracy of scientific discovery including urgently needed COVID-19 research.
UC San Diego researchers recently created a pharmacophore model and conducted data mining of the conformational database of FDA-approved drugs that identifies 64 compounds as potential inhibitors of the COVID-19 protease.